ARTICLE | Clinical News
MOR00208 regulatory update
May 26, 2014 7:00 AM UTC
MorphoSys said FDA granted Orphan Drug designation to MOR208 to treat chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). The company also said it received a positive opinion from ...